Planning

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Hepatitis C Medicines

NHS Wales Shared Services Partnership-Procurement Services

This public procurement record has 2 releases in its history.

Planning

03 Sep 2026 at 17:36

UK2 - Preliminary Market Engagement Notice
Planning

16 Mar 2026 at 16:14

UK1 - Pipeline Notice
Summary of the contracting process

NHS Wales Shared Services Partnership Procurement Services, hosted by Velindre University NHS Trust, intends to buy antiviral medicines for treating hepatitis C (HCV) across NHS Wales. The requirement is for pharmaceutical products supplied as goods, with delivery across Wales. It is intended to support NHS Wales health boards and trusts in providing treatment for patients with hepatitis C. The procurement concerns a single requirement covering the medicines supply rather than separate service, construction or consultancy work. Suppliers should therefore be active in pharmaceutical manufacturing, wholesaling or distribution, with products and supply arrangements suitable for NHS use. The buyer is acting on behalf of NHS Wales health boards and trusts, so the requirement may suit businesses able to manage health-service supply at a Wales-wide level.

This is a planned procurement: the buyer has announced its intention to procure but has not yet invited tenders. The buyer expects the tender notice to be published by 1 October 2026. It expects to use an above-threshold open procedure and a framework agreement. The procurement has one planned lot, with a contract period expected to run from 1 May 2027 to 30 April 2029, with possible renewal or extension to 30 April 2031. The estimated value is £13,454,112 excluding VAT, or £16,144,934.40 including VAT. The buyer has scheduled an initial information milestone for 18 September 2026 and invites suppliers seeking information before publication to make contact. The lot is planned and identified as suitable for SMEs.

The requirement is likely to suit pharmaceutical companies, medicines wholesalers and specialist distributors with established capability in antiviral medicines for hepatitis C. Suppliers should be able to source, store and distribute pharmaceutical products reliably across Wales and support supply to multiple NHS health boards and trusts. Experience of NHS medicines procurement, public-sector framework agreements, pharmaceutical quality requirements and regulated medicines supply would place businesses in a strong position when the tender reaches the market. The scale and Wales-wide delivery requirement favour organisations with dependable stock access, robust logistics, continuity-of-supply arrangements and the capacity to serve health-service demand over several years. The buyer has indicated that the lot is suitable for SMEs, so smaller medicines suppliers may be able to prepare to participate, potentially using suitable distribution or manufacturing partners.

How relevant is this notice?

Notice Information

Notice Title

Hepatitis C Medicines

Notice Description

This tender is for the provision of antiviral medicines for the treatment of Hepatitis C (HCV) to NHS Wales.

Planning Information

This notice is being issued to advise suppliers of a forthcoming opportunity that is due to be published by Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts). There is no formal engagement process for this opportunity. Any suppliers who may like more information on this opportunity before the tender is published please contact Ryan Zobole (ryan.zobole@wales.nhs.uk).

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-066b74
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/083668-2026
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
UK2 - Preliminary Market Engagement Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£13,454,112 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
3 Sep 20261 months ago
Submission Deadline
Not specified
Future Notice Date
1 Oct 2026Expired
Award Date
Not specified
Contract Period
1 May 2027 - 30 Apr 2029 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS Wales Shared Services Partnership-Procurement Services
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
CARDIFF
Postcode
CF14 3UZ
Postcode Area
Cardiff
Country
Wales
Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL52 Cardiff and Vale of Glamorgan
Delivery Location
TLL Wales
Local Authority
Cardiff
Electoral Ward
Gabalfa
Westminster Constituency
Cardiff North

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...